Keyphrases
In Cancer
43%
Multinational Association of Supportive Care in Cancer
38%
Mucositis
38%
Cancer Patients
38%
Clinical Practice Guidelines
33%
Narrative Review
33%
Cancer-associated Thrombosis
33%
Oral Oncology
22%
International Society
22%
Oral mucositis
22%
Clinical Oncology
19%
Cancer Therapy
17%
Oncology
16%
Congestive Heart Failure
16%
Recurrent Cancer
16%
Solid Tumors
16%
Clinical Significance
16%
Catheter-related Thrombosis
16%
Anesthetics
16%
Daily Care
16%
Coating Agent
16%
Challenging Issues
16%
Delphi Study
16%
Cardiovascular Toxicity
16%
Drug Interactions
16%
Patient Care
16%
Risk Diagnosis
16%
Patient Practice
16%
Toxicity Risk
16%
Left Ventricular Ejection Fraction
16%
Recurrent Venous Thromboembolism
16%
Risk Management
16%
Antimicrobial
16%
Analgesic
16%
Clinical Guidance
16%
Targeted Agents
16%
Meta-analysis
16%
Inpatient Care
16%
Checkpoint Inhibitor Pneumonitis
16%
Lung Cancer Patients
16%
Clinical Care Pathway
16%
Global Excellence
16%
Hypertension
13%
Venous Thromboembolism
11%
Cancer Treatment
10%
Myocardial Infarction
10%
Trastuzumab
10%
Sorafenib
10%
Low Molecular Weight Heparin
9%
Head-and-neck Cancer
8%
Medicine and Dentistry
Malignant Neoplasm
94%
Supportive Care
51%
Thrombosis
50%
Oncology
36%
Solid Malignant Neoplasm
35%
Mucositis
33%
Pneumonia
33%
Immune Checkpoint Inhibitor
33%
Cancer Therapy
25%
Lung Cancer
20%
Cancer Treatment
18%
Hospitalist
16%
Oral Oncology
16%
Cancer Recurrence
16%
Catheter Thrombosis
16%
Clinical Significance
16%
Thrombotic Thrombocytopenic Purpura
16%
Venous Thromboembolism
16%
COVID-19
16%
Care Pathway
16%
Cancer Care
11%
Low Molecular Weight Heparin
10%
Anticoagulation
9%
Direct Oral Anticoagulant
7%
Infection
6%
Clinician
6%
Diseases
6%
Patient Advocate
5%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Mucosa Inflammation
38%
Thrombosis
33%
Diseases
20%
Oral Mucositis
18%
Antiemetic Agent
16%
Nausea and Vomiting
16%
Cardiovascular Toxicity
16%
Congestive Heart Failure
16%
Coronavirinae
16%
Analgesic Agent
16%
Anesthetic Agent
16%
Olanzapine
16%
Advanced Cancer
16%
Pneumonia
16%
Lung Cancer
16%
Immune Checkpoint Inhibitor
16%
Nausea
11%
Heart Infarction
10%
Sorafenib
10%
Trastuzumab
10%
Head and Neck Cancer
8%
Heart Arrhythmia
6%
Sunitinib
6%
Bevacizumab
6%
Low Molecular Weight Heparin
5%
Butyrophenone Derivative
5%
Morphine
5%
Phenothiazine
5%
Atypical Antipsychotic
5%
Serotonin Antagonist
5%
Benzamide Derivative
5%
